Drug Profile
Polyclonal antibody Pylorimune-G
Alternative Names: Pylorimune-GLatest Information Update: 29 Mar 2000
Price :
$50
*
At a glance
- Originator GalaGen
- Developer Chiron Corporation; GalaGen
- Class Polyclonal antibodies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Helicobacter infections
Most Recent Events
- 29 Mar 2000 No-Development-Reported for Helicobacter infections in USA (PO)
- 02 Dec 1998 Discontinued - Preclinical for Helicobacter infections in USA (PO)
- 03 Dec 1997 Preclinical development for Helicobacter infections in USA (PO)